转移性疾病的风险因素,表现为心脏瘤及其预后价值
Ari R Berg1, Gabriel Hanna1, Dhruv Mendiratta1
1Department of Orthopaedics, Rutgers New Jersey Medical School, Newark, New Jersey, United States.
North American Spine Society journal
|January 21, 2025
概括
脱差性胆瘤与诊断时更高的转移风险有关. 高龄和这种亚型独立地预测转移性胆瘤患者的生存率更差,有助于预后和咨询.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 流行病学 流行病学
背景情况:
- 脊髓瘤是一种罕见的,具有破坏性的骨癌,起源于脊髓,主要影响轴骨架.
- 它的转移潜力显著影响患者的生存结果.
- 了解转移风险因素和预后指标对于患者管理至关重要.
研究的目的:
- 在初始诊断时确定预测转移性心脏瘤的危险因素.
- 确定影响转移性心脏瘤患者生存的预后因素.
主要方法:
- 利用监测,流行病学和最终结果 (SEER) 数据库来分类心脏瘤患者.
- 分析了患者和瘤特征,使用转移风险的逻辑回归.
- 使用卡普兰-梅尔估计和考克斯比例危险模型来评估生存率.
主要成果:
- 在1241例轴性骨冠状瘤病例中,9.4%出现了转移.
- 不分化的组织学亚型是呈现时转移性疾病的显著预测因素 (OR = 7.42).
- 高龄 (HR=2.06) 和不分化亚型 (HR=4.7) 是转移性心脏瘤死亡率的独立预测因素.
结论:
- 不分化胆瘤组织学与转移性疾病呈现的可能性更高有关.
- 高龄和不分化亚型是转移性心脏瘤死亡率的关键独立预后因素.
- 识别高风险患者可以提供更好的转移潜力和长期预后咨询.
相关概念视频
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K